Results 111 to 120 of about 93,843 (327)

Evaluation of cabotegravir plus rilpivirine in routine clinical settings in Japan: A multicentre study of efficacy, safety and biomarker dynamics

HIV Medicine, EarlyView.
Abstract Objectives Long‐acting cabotegravir plus rilpivirine (CAB+RPV) offers an alternative to daily oral therapy, but real‐world data in East Asia remain scarce. This study aims to evaluate the impact of CAB+RPV in people with HIV in Japan, focusing on virological outcomes, treatment continuation and inflammatory markers, providing valuable insight ...
Eisuke Adachi, Rumi Minami, Michinori Shirano, Hideta Nakamura, Kazuaki Fukushima, Mayumi Imahashi, Ryoko Sekiya, Yusuke Yoshino, Toshibumi Taniguchi, J‐HIV RWD Collaborative Database Team, Takashi Muramatsu, Yuji Hirai   +11 more
wiley   +1 more source

ALFA-FETOPROTEIN /AFP/, A1-ANTITRYPSIN ACTIVITY AND HBsAg IN NEONATAL HEPATITIS AND BILIARY ATRESIA [PDF]

, 1975
C. Kattamis, Sophia Laskari, A. Constantopoulos, N. Matsaniotis   +3 more
openalex   +1 more source

The prevalence of hepatitis B infection and anti‐HCV antibody in patients with diabetes mellitus

Journal of Diabetes Investigation, EarlyView.
This large‐scale epidemiological study assessed the prevalence of HBV infection and anti‐HCV seropositivity among patients with type 2 diabetes mellitus in Golestan Province, Iran—an HBV‐endemic region. Analysis of data from 31,803 diabetic individuals revealed significant associations between chronic viral hepatitis and metabolic dysfunction ...
Malihe Naderi, Seyed Masoud Hosseini, Vahideh Hamidi, Abdolvahab Moradi   +3 more
wiley   +1 more source

Five‐Year Effectiveness and Renal Safety Following Switching to Tenofovir Alafenamide in Chronic Hepatitis B Patients With Renal Impairment

Journal of Gastroenterology and Hepatology, EarlyView.
ABSTRACT Background and Aim Long‐term nucleos(t)ide analog (NUC) therapy is essential for chronic hepatitis B (CHB) management. However, data on long‐term outcomes, particularly for patients switching to tenofovir alafenamide (TAF) and patients with chronic kidney disease (CKD), remain limited.
Eiichi Ogawa, Motoyuki Kohjima, Toshimasa Koyanagi, Kazufumi Dohmen, Aritsune Ooho, Akira Kawano, Norihiro Furusyo, Eiji Kajiwara, Takeaki Satoh, Kazuhiro Takahashi, Koichi Azuma, Rie Sugimoto, Yasunori Ichiki, Takeshi Senju, Hiromasa Amagase, Masatake Tanaka, Makoto Nakamuta, Hideyuki Nomura, Jun Hayashi, The Kyushu University Liver Disease Study (KULDS) Group   +19 more
wiley   +1 more source

Comparison of Rapid Diagnostic Test with Enzyme-Linked Immunosorbent Assay and PCR for Detection of Hepatitis B Surface Antigen

Ahi Evran Medical Journal
Purpose: Hepatitis B virus (HBV) infection is a global public health problem with significant morbidity and mortality rates and the detection of HBsAg is a very important test for diagnosis.
Melek Bilgin, Mehmet Hakan Taşkın, Esmeray Mutlu Yilmaz, Çiğdem Çekiç Cihan   +3 more
doaj   +1 more source

Red Alga Porphyridium Supports High‐Yield Production of a Functional Chimeric Hepatitis B Surface Antigen With Strong Cellular and Humoral Immunogenicity

Plant Biotechnology Journal, EarlyView.
ABSTRACT Microalgae represent promising production factories for the light‐driven, cost‐effective production of recombinant proteins. The red microalga Porphyridium purpureum displays particularly favourable transgene expression properties due to the episomal maintenance of transformation vectors at high copy numbers in the nucleus.
Ana‐Maria Pantazica, Alexander Hammel, Iuliana Caras, Irina Ionescu, Catalin Tucureanu, Adrian Onu, Maria Murace, Jihong Liu Clarke, Crina Stavaru, Norica Branza‐Nichita, Ralph Bock   +10 more
wiley   +1 more source

CORRELATION BETWEEN SGOT AND SGPT LEVELS WITH POSITIVE HBsAg LEVELS

Journal of Vocational Health Studies
Background: Serum Glutamic Oxaloacetate Transaminase (SGOT) and Serum Glutamic Pyruvic Transaminase (SGPT) are transaminase enzymes used to determine liver damage. The increase in both enzymes can indicate the level of liver cell damage.
Nisa'ur Rosyidah, Erlinda Widyastuti, Annisa Auliya Rahman, Nur Septia Handayani, Belgis   +4 more
doaj   +1 more source

Levamisole and HBsAg positive chronic persistent hepatitis. [PDF]

, 1978
Massimo Masi, Paolo Paolucci, G Timoncini, Michela Fantini, G. Leggieri, F Chiodo, C. Franceschi   +6 more
openalex   +1 more source

Hepatitis B Virus Donor Positive to Recipient Negative (D+/R−) Heart and Lung Transplantation: Analysis From the Organ Procurement and Transplantation Network

Transplant Infectious Disease, EarlyView.
ABSTRACT Introduction In nonendemic areas, transplantation from donors with hepatitis B virus (HBV) to recipients without HBV (D+/R−) has been proposed to expand the donor pool; however, data are limited. We aimed to evaluate the epidemiology of HBV in thoracic organ donors, assess HBV‐related thoracic organ nonuse, and determine the impact of HBV D+/R−
Sara Belga, Robert C. Wright, Stephen B. Lee, Christine M. Durand, Karen Doucette   +4 more
wiley   +1 more source

Features of combined (hbv/hcv-infection) viral lesion of the liver

Терапевтический архив, 2008
Aim. To study clinical, biochemical features, course of combined viral hepatitides, dominant viral activity in combination HBV/HCV infection. Material and methods.
I V Maev, I N Nikushkina, A A Samsonov, A G Aksel'rod   +3 more
doaj